Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 164


A20 Promotes Ripoptosome Formation and TNF-Induced Apoptosis via cIAPs Regulation and NIK Stabilization in Keratinocytes.

Feoktistova M, Makarov R, Brenji S, Schneider AT, Hooiveld GJ, Luedde T, Leverkus M, Yazdi AS, Panayotova-Dimitrova D.

Cells. 2020 Feb 3;9(2). pii: E351. doi: 10.3390/cells9020351.


Differential Gene Expression in Circulating CD14+ Monocytes Indicates the Prognosis of Critically Ill Patients with Sepsis.

Liepelt A, Hohlstein P, Gussen H, Xue J, Aschenbrenner AC, Ulas T, Buendgens L, Warzecha KT, Bartneck M, Luedde T, Trautwein C, Schultze JL, Koch A, Tacke F.

J Clin Med. 2020 Jan 2;9(1). pii: E127. doi: 10.3390/jcm9010127.


Serum Levels of Kisspeptin Are Elevated in Patients with Pancreatic Cancer.

Loosen SH, Luedde M, Lurje G, Spehlmann M, Paffenholz P, Ulmer TF, Tacke F, Vucur M, Trautwein C, Neumann UP, Luedde T, Roderburg C.

Dis Markers. 2019 Oct 20;2019:5603474. doi: 10.1155/2019/5603474. eCollection 2019.


Serum Levels of miR-143 Predict Survival in Critically Ill Patients.

Roderburg C, Koch A, Benz F, Vucur M, Spehlmann M, Loosen SH, Luedde M, Rehse S, Lurje G, Trautwein C, Tacke F, Luedde T.

Dis Markers. 2019 Oct 23;2019:4850472. doi: 10.1155/2019/4850472. eCollection 2019.


[Unknown liver lesions].

Roderburg C, Loosen SH, Bruners P, Luedde T.

Dtsch Med Wochenschr. 2019 Nov;144(23):1651-1664. doi: 10.1055/a-0733-6122. Epub 2019 Nov 21. German.


A Combined Score of Circulating miRNAs Allows Outcome Prediction in Critically Ill Patients.

Roderburg C, Benz F, Koch A, Loosen SH, Spehlmann M, Luedde M, Wree A, Vucur M, Trautwein C, Tacke F, Luedde T.

J Clin Med. 2019 Oct 9;8(10). pii: E1644. doi: 10.3390/jcm8101644.


Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies.

Loosen SH, Schulze-Hagen M, Bruners P, Tacke F, Trautwein C, Kuhl C, Luedde T, Roderburg C.

Cancers (Basel). 2019 Oct 8;11(10). pii: E1503. doi: 10.3390/cancers11101503.


Chemoembolization with Degradable Starch Microspheres for Treatment of Patients with Primary or Recurrent Unresectable, Locally Advanced Intrahepatic Cholangiocarcinoma: A Pilot Study.

Goerg F, Zimmermann M, Bruners P, Neumann U, Luedde T, Kuhl C.

Cardiovasc Intervent Radiol. 2019 Dec;42(12):1709-1717. doi: 10.1007/s00270-019-02344-0. Epub 2019 Oct 2.


The Role of Adipokines as Circulating Biomarkers in Critical Illness and Sepsis.

Loosen SH, Koch A, Tacke F, Roderburg C, Luedde T.

Int J Mol Sci. 2019 Sep 28;20(19). pii: E4820. doi: 10.3390/ijms20194820. Review.


Life is fragile: FMRP controls cell death in liver disease.

Vucur M, Luedde T.

Gut. 2020 Jan;69(1):2-3. doi: 10.1136/gutjnl-2019-319534. Epub 2019 Sep 25. No abstract available.


Correction to: Neutrophils are a main source of circulating suPAR predicting outcome in critical illness.

Gussen H, Hohlstein P, Bartneck M, Warzecha KT, Buendgens L, Luedde T, Trautwein C, Koch A, Tacke F.

J Intensive Care. 2019 Aug 2;7:40. doi: 10.1186/s40560-019-0397-x. eCollection 2019.


An NF-kappaB- and IKK-Independent Function of NEMO Prevents Hepatocarcinogenesis by Suppressing Compensatory Liver Regeneration.

Koppe C, Reisinger F, Wehr K, Vucur M, Trautwein C, Tacke F, Heikenwalder M, Luedde T.

Cancers (Basel). 2019 Jul 17;11(7). pii: E999. doi: 10.3390/cancers11070999.


Excellent Response to Anti-PD-1 Therapy in a Patient with Hepatocellular Carcinoma Intolerant to Sorafenib.

Roderburg C, Berres ML, Wree A, Loosen SH, Luedde T, Trautwein C.

Visc Med. 2019 Mar;35(1):43-46. doi: 10.1159/000497465. Epub 2019 Feb 12.


Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia.

Herrmann O, Kuepper MK, Bütow M, Costa IG, Appelmann I, Beier F, Luedde T, Braunschweig T, Koschmieder S, Brümmendorf TH, Schemionek M.

BMC Cancer. 2019 Jul 4;19(1):658. doi: 10.1186/s12885-019-5871-2.


Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer.

Kather JN, Pearson AT, Halama N, Jäger D, Krause J, Loosen SH, Marx A, Boor P, Tacke F, Neumann UP, Grabsch HI, Yoshikawa T, Brenner H, Chang-Claude J, Hoffmeister M, Trautwein C, Luedde T.

Nat Med. 2019 Jul;25(7):1054-1056. doi: 10.1038/s41591-019-0462-y. Epub 2019 Jun 3.


Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis.

Krenkel O, Hundertmark J, Abdallah AT, Kohlhepp M, Puengel T, Roth T, Branco DPP, Mossanen JC, Luedde T, Trautwein C, Costa IG, Tacke F.

Gut. 2020 Mar;69(3):551-563. doi: 10.1136/gutjnl-2019-318382. Epub 2019 May 10.


Neutrophils are a main source of circulating suPAR predicting outcome in critical illness.

Gussen H, Hohlstein P, Bartneck M, Warzecha KT, Buendgens L, Luedde T, Trautwein C, Koch A, Tacke F.

J Intensive Care. 2019 Apr 27;7:26. doi: 10.1186/s40560-019-0381-5. eCollection 2019. Erratum in: J Intensive Care. 2019 Aug 2;7:40.


Characterization of HCC Mouse Models: Towards an Etiology-Oriented Subtyping Approach.

Friemel J, Frick L, Unger K, Egger M, Parrotta R, Böge YT, Adili A, Karin M, Luedde T, Heikenwalder M, Weber A.

Mol Cancer Res. 2019 Jul;17(7):1493-1502. doi: 10.1158/1541-7786.MCR-18-1045. Epub 2019 Apr 9.


Liver fibrosis affects the targeting properties of drug delivery systems to macrophage subsets in vivo.

Ergen C, Niemietz PM, Heymann F, Baues M, Gremse F, Pola R, van Bloois L, Storm G, Kiessling F, Trautwein C, Luedde T, Lammers T, Tacke F.

Biomaterials. 2019 Jun;206:49-60. doi: 10.1016/j.biomaterials.2019.03.025. Epub 2019 Mar 22.


miR-155 Predicts Long-Term Mortality in Critically Ill Patients Younger than 65 Years.

Tacke F, Spehlmann ME, Vucur M, Benz F, Luedde M, Cardenas DV, Roy S, Loosen S, Hippe HJ, Frey N, Trautwein C, Koch A, Roderburg C, Luedde T.

Mediators Inflamm. 2019 Feb 24;2019:6714080. doi: 10.1155/2019/6714080. eCollection 2019.

Supplemental Content

Loading ...
Support Center